After a series of challenges in 2024, Belgium's beverage giant AB InBev (NYSE:BUD), the maker of Budweiser and Corona, dipped deeper to 27.54% below its one-year high following the Surgeon General ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback